Conflict$ Australia – Prof Jodie McVERNON

Back to Conflicts of Interest Australia COVID Policy [Part 1]

• In 2018 Member of the “Influenza Working Party” which prepares advice for ATAGI ^{(01)  ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf}
• Member of ATAGI’s “Pertussis Working Party” which prepare advice on the epidemiology of pertussis and potential vaccination strategies in Australia ^{(02) ATAGI’s Pertussis Working Party: https://www.health.gov.au/sites/default/files/pertussis-working-party.pdf}
• Director of Influenza Specialist Group ^{(03) ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf} which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi ^{(04) Influenza Specialist Group (ISG) Sponsors: http://www.isg.org.au/index.php/about/sponsorship-and-support/ .}  
• Received funding from the Australian Research Council (ARC) for vaccine clinical trial investigations ^{(05) ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}
• Travel covered to attend a number of workshops and symposiums sponsored by vaccine companies ^{(06) ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}
• Investigator on clinical trials funded by vaccine manufacturers GlaxoSmithKline, bioCSL, Novartis and Pfizer ^{(07) ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf .}
• Member of Asia-Pacific Alliance for the Control of Influenza (APACI) ^{(08) Asia-Pacific Alliance for the Control of Influenza (APACI) Members: https://www.apaci.asia/about-apaci/membership} , which has received funds from vaccine manufacturers IFPMA, Roche and Seqirus/CSL ^{(09) Asia-Pacific Alliance for the Control of Influenza (APACI) Funding: https://www.apaci.asia/about-apaci/support-grants}
• Jodie McVernon is currenty part of the Peter Doherty Institute for Infection & Immunity, COVID-19 Research team ^{(10) Doherty Institute COVID-19 Research team: https://www.doherty.edu.au/our-work/institute-themes/viral-infectious-diseases/covid-19/covid-19-research .}
• Member of ATAGI’s COVID-19 Working Group ⁽¹¹⁾ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.

McVernon has just been appointed “Office of the Order of Australia”

Posts tagged: ATAGI, CSL, Doherty, GSK, Novartis, Pfizer, Roche, Sanofi

Back to Conflicts of Interest Australia COVID Policy [Part 1]